Natalia Smaglyukova,
Elise Thoresen Sletten,
Anne Ørbo,
Georg Sager
:
Data on RT-qPCR assay of nuclear progesterone receptors (nPR), membrane progesterone receptors (mPR) and progesterone receptor membrane components (PGRMC) from human uterine endometrial tissue and cancer cells of the uterine cervix
Elise Thoresen Sletten,
Natalia Smaglyukova,
Anne Ørbo,
Georg Sager
:
Expression of nuclear progesterone receptors (nPR), membrane progesterone receptors (mPR) and progesterone receptor membrane components (PGRMC) in the human endometrium after 6 months levonorgestrel low dose intrauterine therapy,
Journal of Steroid Biochemistry and Molecular Biology 2020
ARKIV /
DOI
Elise Thoresen Sletten,
Marit Arnes,
Lena Marianne Myreng Lyså,
Marthe Larsen,
Anne Ørbo
:
Significance of progesterone receptors (PR-A and PR-B) expression as predictors for relapse after successful therapy of endometrial hyperplasia: a retrospective cohort study
BJOG: An International Journal of Obstetrics and Gynaecology 2019
ARKIV /
DOI
Elise Thoresen Sletten,
Marit Arnes,
Anne Beate Vereide,
Anne Ørbo
:
Intrauterine progestin therapy as a new approach to premalignant endometrial polyps: A prospective observational study
Elise Thoresen Sletten,
Marit Arnes,
Anne Beate Vereide,
Anne Ørbo
:
Low-dose LNG-IUS as therapy for endometrial hyperplasia. A prospective cohort pilot study
Anticancer Research 2018
DOI
Elise Thoresen Sletten,
Marit Arnes,
Lena Marianne Myreng Lyså,
Bjørn Thorvald Greve Moe,
Bjørn Straume,
Anne Ørbo
:
Prediction of relapse after therapy withdrawal in women with endometrial hyperplasia: A long-term follow-up study
Anticancer Research 2017
DOI
Anne Ørbo,
Marit Arnes,
Anne Beate Vereide,
Bjørn Straume
:
Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens
BJOG: An International Journal of Obstetrics and Gynaecology 2016
ARKIV /
DOI
Anne Ørbo,
Marit Arnes,
Lena Marianne Myreng Lyså,
Christer Borgfelt,
Bjørn Straume
:
HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
British Journal of Cancer 2016
ARKIV /
DOI
Anne Ørbo,
Marit Arnes,
Lena Marianne Myreng Lyså,
Bjørn Straume
:
Expression of PAX2 and PTEN correlates to therapy response in endometrial hyperplasia
Anne Ørbo,
Anne Beate Vereide,
Marit Arnes,
Inger Pettersen,
Bjørn Straume
:
Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: A national multicentre randomised trial
BJOG: An International Journal of Obstetrics and Gynaecology 2014
ARKIV /
DOI
Marit Arnes,
Bodil Hvingel,
Anne Ørbo
:
Levonorgestrel-impregnated intrauterine device reduces occurrence of hyperplastic polyps: A population-based follow-up cohort study
Anticancer Research 2014
DOI
Tormod Eggen,
Georg Sager,
Thomas Berg,
Birgitte Nergaard,
Bjørn Torvald Greve Moe,
Anne Ørbo
:
Increased Gene Expression of the ABCC5 Transporter without Distinct Changes in the Expression of PDE5 in Human Cervical Cancer Cells during Growth
Bodil Hvingel,
Marit Lieng,
Borghild Roald,
Anne Ørbo
:
Vascular markers CD31, CD34, actin, VEGFB, and VEGFR2, are prognostic markers for malignant development in benign endometrial polyps
Open Journal of Obstetrics and Gynecology 2012
DOI
Tormod Eggen,
Georg Sager,
Marit Arnes,
Inger Pettersen,
Anne Ørbo
:
Expression of iNOS - A Favourable Prognostic Marker for Early-stage Carcinoma of the Uterine Cervix
Anticancer Research 2011
Renathe Fjelldal,
Bjørn Torvald Greve Moe,
Anne Ørbo,
Georg Sager
:
MCF-7 Cell Apoptosis and Cell Cycle Arrest: Non-genomic Effects of Progesterone and Mifepristone (RU-486)
Anticancer Research 2010
Anne Ørbo,
Marit Arnes,
Inger Pettersen,
Kurt Larsen,
Karin Johanne Hanssen,
Bjørn Torvald Greve Moe
:
Down-regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system
Acta Obstetricia et Gynecologica Scandinavica 2010
DOI
Anne Ørbo,
Bjørn Torvald Greve Moe,
Marit Arnes,
Inger Pettersen,
Kari Margrethe Larsen,
Tormod Eggen
et al.:
Prognostic markers for detection of coexistent carcinoma in high-risk endometrial hyperplasia
Anticancer Research 2010
Bjørn Torvald Greve Moe,
Anne Beate Vereide,
Anne Ørbo,
ragnhild JÆger,
Georg Sager
:
Levonorgestrel, Medroxyprogesterone and Progesterone Cause a Concentration-dependent Reduction in Endometrial Cancer (Ishikawa) Cell Density, and High Concentrations of Progesterone and Mifepristone Act in Synergy
Anticancer Research 2009
Anne Ørbo,
Bjørn Torvald Greve Moe,
Halvor Grønaas,
Ruth H Paulssen
:
Early effects of high concentrations of progesterone and Mifepristone. A gene expression study of endometrial cancer cells (ishikawa)
Journal of Steroid Biochemistry and Molecular Biology 2009
DOI
Bjørn Torvald Greve Moe,
Anne Beate Vereide,
Anne Ørbo,
Georg Sager
:
High Concentrations of Progesterone and Mifepristone Mutually Reinforce Cell Cycle Retardation and Induction of Apoptosis
Anticancer Research 2009
Ruth H Paulssen,
Bjørn Moe,
Halvor Grønaas,
Anne Ørbo
:
Gene expression in endometrial cancer cells (Ishikawa)after short time high exposure to progesterone
Anne Ørbo,
marit Arnes,
Christine Hancke,
Anne Beate Vereide,
Inger Pettersen,
Kurt Larsen
:
Treatment results of endometrial hyperplasia after prospective D-score classification - A follow-up study comparing effect of LNG-IUD and oral progestins versus observation only
Gynecologic Oncology 2008
DOI
Ruth H Paulssen,
Bjørn Moe,
Halvor Grønaas,
Anne Ørbo
:
Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone
Anne Ørbo,
Målfrid Hanevik,
ragnhild JÆger,
Saskia Van Heusden,
Georg Sager
:
Urinary cyclic GMP after treatment of gynecological cancer. A prognostic marker of clinical outcome
Anticancer Research 2007
Tormod Eggen,
Marit Arnes,
Bjørn greve Moe,
Bjørn Straume,
Pia Marika Østman,
Anne Ørbo
:
Prognosis of early cervical cancer (FIGO stages IA2, IB, and IIA) in Northern Norway predicted by malignancy grading score and objective morphometric image analysis
International Journal of Gynecological Pathology 2007
DOI
Anne Ørbo,
Cecil E Rise,
George L Mutter
:
Regression of latent endometrial precancers by progestin infiltrated intrauterine device
Cancer Research 2006
Anne Beate Vereide,
Turid Kaino,
Georg Sager,
Marit Arnes,
Anne Ørbo
:
Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia
Gynecologic Oncology 2006
Anne Ørbo
:
Spiral hindrer kreft
18. December 2013
Morten R. Høyning,
Anne Ørbo
:
Vil hindre kreft - Tusenvis av kvinner kan få hjelp av prevensjonsmiddel
18. December 2013
Eirik Linaker Berglund,
Anne Ørbo
:
Ny forskning slår fast: P-spiral stopper livmorkreften
16. December 2013
Morten R. Høyning,
Anne Ørbo
:
Prevensjonsmiddel vil hindre kreft hos tusenvis av kvinner
17. December 2013
Anne Ørbo,
Signe Tynning
:
Forskjellig bruk av hormonspiral
30. January 2013
Eirik Linaker Berglund,
Anne Ørbo
:
UiT-forsker i spissen for kreftsensasjon
16. December 2013
Bjørn Thorvald Greve Moe,
Anne Ørbo,
Georg Sager,
Anne Beate Vereide
:
Extranuclear steroid-initiated signaling by progestin and mifepristone: concentration-dependent inhibition of Ishikawa cell proliferation and induction of apoptosis
Virchows Archiv 2011
Anne Ørbo,
marit Arnes,
Inger Pettersen,
Kurt Larsen,
Karin Johanne Hanssen,
Bjørn Torvald Greve Moe
:
Successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system coincides with down-regulated progesterone receptor A and B
Virchows Archiv 2011
Anne Ørbo,
B Moe,
I Pettersen,
M Arnes,
K Hanssen
:
Diagnostics of coexistent endometrial carcinoma in high-risk endometrial hyperplasia: significance of the 4c-rule and EIN for outcome prediction
Virchows Archiv 2011
Ruth H Paulssen,
Bjørn Moe,
Halvor Grønaas,
Anne Ørbo
:
Gene expression in endometrial cancer cells (ishikawa) after short time high dose exposure to progestins
Virchows Archiv 2007
Anne Ørbo
:
Bakgrunn for Levonovastsudien
2007
Anne Ørbo,
Christine Hancke
:
Status for prospektiv randomisert nasjonal studie (RCT) om behandling av forstadier til livmorkreft - Levonovastudien
2007
Anne Ørbo
:
Årsrapport - kunnskapscelle for gynekologisk onkologi/gynekologisk patologi-2006
2007
Anne Ørbo,
Turid Kaino,
Georg Sager,
Marit Arnes
:
Bcl-2, BAX and apoptosis in endometrial hyperplasia after high dose gestagen therapy A comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone
2007
Tormod Eggen,
Marit Arnes,
Bjørn greve Moe,
Anne Ørbo
:
Prognosis of squamous cell carcinoma (Figo stage Ia2, Ib and IIa) of the uterine cervix predicted by malignancy grading score evaluation
2007
Anne Ørbo,
Bjørn greve Moe,
Georg Sager,
Anne Beate Vereide
:
Extranuclear steroid-initiated signaling by progestin and mifepristone
2007
Anne Ørbo
:
Lichen sclerosus / diagnostikk og behandling Årsmøte NNFOG Stokmarknes , 19-21 april 2007
2007
Anne Ørbo
:
Uavklarte tilstander ved cervixcytologi Årsmøte NNFOG Stokmarknes, 19- april 2007
2007
Anne Ørbo
:
Fra forskning til klnisk praksis, Årsmøte NNFOG Stokmarknes , 19-21 april 2007
2007
Anne Ørbo,
Marit Arnes,
Inger Pettersen,
Kurt Larsen
:
A study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone as treatment for endometrial hyperplasia. Assessment by light microscopy and morphometry
2007
Anne Ørbo
:
Kan man forebygge utvikling av livmorkreft
2007
Anne Ørbo,
Anne Beate Vereide
:
Status for levonovastudien
2006
Anne Beate Vereide,
Anne Ørbo
:
Hva fikk vi ut av pilotstudien
2006